Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.740
-0.110 (-2.86%)
At close: Dec 5, 2025, 4:00 PM EST
3.850
+0.110 (2.94%)
After-hours: Dec 5, 2025, 7:58 PM EST
Prime Medicine Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 662 | 373 | 817 | 1,609 | - | - | |
| Market Cap Growth | 63.18% | -54.41% | -49.22% | - | - | - | |
| Enterprise Value | 567 | 238 | 669 | 1,890 | - | - | |
| Last Close Price | 3.74 | 2.92 | 8.86 | 18.58 | - | - | |
| PS Ratio | 85.83 | 124.90 | - | - | - | - | |
| PB Ratio | 4.09 | 2.43 | 6.14 | 5.09 | - | - | |
| P/TBV Ratio | 4.09 | 2.43 | 6.14 | 5.09 | - | - | |
| EV/Sales Ratio | 94.86 | 79.89 | - | - | - | - | |
| Debt / Equity Ratio | 0.73 | 0.27 | 0.10 | 0.09 | 0.04 | 0.52 | |
| Asset Turnover | 0.02 | 0.01 | - | - | - | 0.16 | |
| Quick Ratio | 6.09 | 5.02 | 2.16 | 11.00 | 4.65 | 2.74 | |
| Current Ratio | 6.61 | 5.58 | 2.53 | 11.10 | 4.67 | 2.75 | |
| Return on Equity (ROE) | -112.34% | -136.88% | -88.19% | -43.83% | -121.13% | -19.56% | |
| Return on Assets (ROA) | -35.52% | -51.51% | -43.15% | -22.00% | -29.61% | -1.84% | |
| Return on Capital (ROIC) | -49.92% | -74.30% | -48.63% | -24.48% | -35.09% | -2.22% | |
| Return on Capital Employed (ROCE) | -58.30% | -78.00% | -139.20% | -34.90% | -34.60% | -2.60% | |
| Earnings Yield | -29.80% | -52.58% | -24.25% | -7.57% | - | - | |
| FCF Yield | -17.38% | -34.94% | -21.31% | -9.19% | - | - | |
| Buyback Yield / Dilution | -25.86% | -30.37% | -168.41% | -161.23% | -391.47% | -77.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.